(2014). Transition at Teva - Blockbuster Drug Copaxone to Lose Patent Protection in 2014. Marketline.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita Chicago Style (17a ed.)
Transition at Teva - Blockbuster Drug Copaxone to Lose Patent Protection in 2014. Marketline, 2014.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita MLA (9a ed.)
Transition at Teva - Blockbuster Drug Copaxone to Lose Patent Protection in 2014. Marketline, 2014.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.